Literature DB >> 16739821

Are drugs too expensive in Canada? Yes.

Joel Lexchin1.   

Abstract

Mesh：

Year:  2006        PMID： 16739821      PMCID： PMC1531713     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

2.  Returns on research and development for 1990s new drug introductions.

Authors:  Henry Grabowski; John Vernon; Joseph A DiMasi
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Industrial interests versus public health: the gap is growing.

Authors: 
Journal:  Prescrire Int       Date:  2004-04

Review 4.  Can the pharmaceutical industry reduce attrition rates?

Authors:  Ismail Kola; John Landis
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

5.  Public and private pharmaceutical spending as determinants of health outcomes in Canada.

Authors:  Pierre-Yves Crémieux; Marie-Claude Meilleur; Pierre Ouellette; Patrick Petit; Martin Zelder; Ken Potvin
Journal:  Health Econ       Date:  2005-02       Impact factor: 3.046

6.  Cost of innovation in the pharmaceutical industry.

Authors:  J A DiMasi; R W Hansen; H G Grabowski; L Lasagna
Journal:  J Health Econ       Date:  1991-07       Impact factor: 3.883

7.  The economics of follow-on drug research and development: trends in entry rates and the timing of development.

Authors:  Joseph A DiMasi; Cherie Paquette
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Extraordinary claims require extraordinary evidence.

Authors:  Donald W Light; Rebecca N Warburton
Journal:  J Health Econ       Date:  2005-09       Impact factor: 3.883
  8 in total
  2 in total

1.  And the winner is...

Authors:  Don Eby
Journal:  Can Fam Physician       Date:  2006-07       Impact factor: 3.275

Review 2.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.